Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Aineistotyyppi: Artikkeli
Kieli:Russian
Julkaistu: «REMEDIUM GROUP» Ltd. 2023-01-01
Sarja:Атеротромбоз
Aiheet:
active cancer
multifocal atherosclerosis
d-dimer
gdf-15
vegf-a
prognosis determining outcomes
Linkit:https://www.aterotromboz.ru/jour/article/view/287

Internet

https://www.aterotromboz.ru/jour/article/view/287

Samankaltaisia teoksia